Citigroup’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37M | Sell |
|
|||||
|
2025
Q1 | $3.12M | Buy |
|
|||||
|
2024
Q4 | $3M | Buy |
|
|||||
|
2024
Q3 | $2.56M | Buy |
|
|||||
|
2024
Q2 | $1.22M | Buy |
|
|||||
|
2024
Q1 | $969K | Buy |
|
|||||
|
2023
Q4 | $889K | Buy |
|
|||||
|
2023
Q3 | $526K | Sell |
|
|||||
|
2023
Q2 | $1.16M | Buy |
|
|||||
|
2023
Q1 | $912K | Sell |
|
|||||
|
2022
Q4 | $866K | Sell |
|
|||||
|
2022
Q3 | $3.65M | Buy |
|
|||||
|
2022
Q2 | $3.27M | Buy |
|
|||||
|
2022
Q1 | $2.69M | Sell |
|
|||||
|
2021
Q4 | $6.51M | Buy |
|
|||||
|
2021
Q3 | $4.98M | Buy |
|
|||||
|
2021
Q2 | $4.62M | Buy |
|
|||||
|
2021
Q1 | $4.41M | Buy |
|
|||||
|
2020
Q4 | $545K | Buy |
|
|||||
|
2020
Q3 | $215K | Sell |
|
|||||
|
2020
Q2 | $1.9M | Sell |
|
|||||
|
2020
Q1 | $1.85M | Buy |
|
|||||
|
2019
Q4 | $1.62M | Sell |
|
|||||
|
2019
Q3 | $1.59M | Buy |
|
|||||
|
2019
Q2 | $1.65M | Sell |
|
|||||
|
2019
Q1 | $2.53M | Sell |
|
|||||
|
2018
Q4 | $8.38M | Buy |
|
|||||
|
2018
Q3 | $7.19M | Buy |
|
|||||
|
2018
Q2 | $1.49M | Sell |
|
|||||
|
2018
Q1 | $4.43M | Sell |
|
|||||
|
2017
Q4 | $4.98M | Buy |
|
|||||
|
2017
Q3 | $4.24M | Sell |
|
|||||
|
2017
Q2 | $3.92M | Buy |
|
|||||
|
2017
Q1 | $3.15M | Sell |
|
|||||
|
2016
Q4 | $8.61M | Buy |
|
|||||
|
2016
Q3 | $1.57M | Buy |
|
|||||
|
2016
Q2 | $719K | Sell |
|
|||||
|
2016
Q1 | $1.39M | Sell |
|
|||||
|
2015
Q4 | $4.24M | Buy |
|
|||||
|
2015
Q3 | $3.2M | Buy |
|
|||||
|
2015
Q2 | $133K | Sell |
|
|||||
|
2015
Q1 | $136K | Sell |
|
|||||
|
2014
Q4 | $681K | Buy |
|
|||||
|
2014
Q3 | $468K | Buy |
|
|||||
|
2014
Q2 | $56K | Sell |
|
|||||
|
2014
Q1 | $80K | Sell |
|
|||||
|
2013
Q4 | $355K | Buy |
|
|||||
|
2013
Q3 | $175K | Buy |
|
|||||
|
2013
Q2 | $7K | Buy |
|